| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |